» Articles » PMID: 28931761

Periodontal-induced Chronic Inflammation Triggers Macrophage Secretion of Ccl12 to Inhibit Fibroblast-mediated Cardiac Wound Healing

Abstract

Chronic inflammatory diseases, such as periodontal disease, associate with adverse wound healing in response to myocardial infarction (MI). The goal of this study was to elucidate the molecular basis for impaired cardiac wound healing in the setting of periodontal-induced chronic inflammation. Causal network analysis of 168 inflammatory and extracellular matrix genes revealed that chronic inflammation induced by a subseptic dose of Porphyromonas gingivalis lipopolysaccharide (LPS) exacerbated infarct expression of the proinflammatory cytokine Ccl12. Ccl12 prevented initiation of the reparative response by prolonging inflammation and inhibiting fibroblast conversion to myofibroblasts, resulting in diminished scar formation. Macrophage secretion of Ccl12 directly impaired fibronectin and collagen deposition and indirectly stimulated collagen degradation through upregulation of matrix metalloproteinase-2. In post-MI patients, circulating LPS levels strongly associated with the Ccl12 homologue monocyte chemotactic protein 1 (MCP-1). Patients with LPS levels ≥ 1 endotoxin units (EU)/ml (subseptic endotoxemia) at the time of hospitalization had increased end diastolic and systolic dimensions compared with post-MI patients with < 1 EU/ml, indicating that low yet pathological concentrations of circulating LPS adversely impact post-MI left ventricle (LV) remodeling by increasing MCP-1. Our study provides the first evidence to our knowledge that chronic inflammation inhibits reparative fibroblast activation and generates an unfavorable cardiac-healing environment through Ccl12-dependent mechanisms.

Citing Articles

Causal relationship between immune cells and risk of heart failure: evidence from a Mendelian randomization study.

Cao W, Yang Z, Mo L, Liu Z, Wang J, Zhang Z Front Cardiovasc Med. 2025; 11:1473905.

PMID: 39917605 PMC: 11798955. DOI: 10.3389/fcvm.2024.1473905.


Perivascular Adipose Tissue Becomes Pro-Contractile and Remodels in an IL10 Colitis Model of Inflammatory Bowel Disease.

Jenkins 3rd S, Grunz E, Ramos K, Boerman E Int J Mol Sci. 2024; 25(19.

PMID: 39409054 PMC: 11476586. DOI: 10.3390/ijms251910726.


Secreted chemokines reveal diverse inflammatory and degenerative processes in the intervertebral disc of the STZ-HFD mouse model of Type 2 diabetes.

Gonzalez C, Vaidya R, Clayton S, Clayton S, Tang S bioRxiv. 2024; .

PMID: 39131361 PMC: 11312574. DOI: 10.1101/2024.07.31.605332.


Cardiac fibroblasts: answering the call.

Kleinbongard P, Senyo S, Lindsey M, Garvin A, Simpson J, de Castro Braz L Am J Physiol Heart Circ Physiol. 2024; 327(3):H681-H686.

PMID: 39093000 PMC: 11442096. DOI: 10.1152/ajpheart.00478.2024.


Combinatorial macrophage induced innate immunotherapy against Ewing sarcoma: Turning "Two Keys" simultaneously.

Luo W, Hoang H, Miller K, Zhu H, Xu S, Mo X J Exp Clin Cancer Res. 2024; 43(1):193.

PMID: 38992659 PMC: 11238356. DOI: 10.1186/s13046-024-03093-w.


References
1.
Xia J, Sinelnikov I, Han B, Wishart D . MetaboAnalyst 3.0--making metabolomics more meaningful. Nucleic Acids Res. 2015; 43(W1):W251-7. PMC: 4489235. DOI: 10.1093/nar/gkv380. View

2.
Cekici A, Kantarci A, Hasturk H, Van Dyke T . Inflammatory and immune pathways in the pathogenesis of periodontal disease. Periodontol 2000. 2013; 64(1):57-80. PMC: 4500791. DOI: 10.1111/prd.12002. View

3.
Humphrey L, Fu R, Buckley D, Freeman M, Helfand M . Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis. J Gen Intern Med. 2008; 23(12):2079-86. PMC: 2596495. DOI: 10.1007/s11606-008-0787-6. View

4.
Van Linthout S, Miteva K, Tschope C . Crosstalk between fibroblasts and inflammatory cells. Cardiovasc Res. 2014; 102(2):258-69. DOI: 10.1093/cvr/cvu062. View

5.
Martinez F, Gordon S . The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014; 6:13. PMC: 3944738. DOI: 10.12703/P6-13. View